Join the Campaign

Specialty Pharmacy

Share This Page

Specialty Pharmacy

Specialty pharmacy focuses on high cost, high touch medication therapy for patients with complex disease states. Medications in specialty pharmacy range from oral to cutting edge injectable and biologic products. The disease states treated range from cancer, multiple sclerosis and rheumatoid arthritis to rare genetic conditions.  

A specialty pharmacist may work in a variety of practice settings. Some pharmacists in this practice area work in pharmacies dedicated to only products that are considered specialty medications. In this setting, pharmacists may work in a variety of areas including dispensing, medication therapy management, patient advocacy and therapy compliance. Some pharmacists work in institutional or health system settings and may be involved with the patients therapy from in-patient to ambulatory care sites. Other pharmacists work in more traditional retail settings and either focus on certain specialty disease states at their practice sites or work with an affiliated specialty pharmacy provider to dispense these complex medications.  

SPECIALTY COVERAGE
August 18, 2017
August 18, 2017
A new clinical guideline from the American Gastroenterological Association (AGA) conditionally recommends reactive therapeutic drug monitoring (TDM...
A new clinical guideline from the American Gastroenterological Association (AGA) conditionally recommends reactive therapeutic drug monitoring (TDM) to guide treatment changes in adults with active inflammatory bowel disease (IBD) treated with anti-TNF agents.
MORE
August 18, 2017
August 18, 2017
FDA approved on August 17 inotuzumab ozogamicin (Besponsa—Pfizer) for the treatment of adults with relapsed or refractory B-cell precursor acute...
FDA approved on August 17 inotuzumab ozogamicin (Besponsa—Pfizer) for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). The targeted therapy is thought to work by binding to B-cell ALL cancer cells that express the CD22 antigen, blocking the growth of cancerous cells.
MORE
August 07, 2017
August 07, 2017
PT article
MORE
  • Join the Campaign
  • Take Action ALT Text
  • Get the facts ALT text
LATEST NEWS
August 14, 2017
August 14, 2017
Tennessee saw major provider status legislation take effect on July 1. “Pharmacists as Providers” (HB 405/SB 461) gives Tennessee pharmacists formal...
‘Pharmacists as providers’ legislation went into effect July 1
MORE
July 13, 2017
July 13, 2017
The Massachusetts Senate and House of Representatives health care committee held a hearing on legislation that would expand the scope of practice...
Hearing held last month included testimony from pharmacists and physicians
MORE
May 22, 2017
What an interesting week!  Last week, APhA Senior Vice President of Pharmacy Practice and Government Affairs Stacie Maass and I joined a small group...
MORE
Advertisement